15-Deoxy ⌬12,14 -prostaglandin J 2 (15d-PGJ 2 ), an activator of peroxisome proliferator-activated receptor (PPAR)-␥ and -␦, is a prostanoid metabolite with anti-inflammatory actions. In intrauterine tissues, proinflammatory cytokines and prostaglandins have been identified as playing key roles in the maintenance of pregnancy and the onset of labor. We investigated and compared the early (Ͻ3 h) effects of 15d-PGJ 2 with rosiglitazone (PPAR-␥ ligand) and 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-thiazol-5-yl)-methylsulfanyl)phenoxy-acetic acid (GW501516) (PPAR-␦ ligand) on interleukin (IL)-1-induced prostaglandin and cytokine production by amnion-derived WISH cells. We show that 15d-PGJ 2 exerts differential effects depending on concentration. At low concentrations (Ͻ0.1 M), 15d-PGJ 2 inhibited IL-1-stimulated prostaglandin E 2 (PGE 2 ) but not cytokine (IL-6/IL-8) production or cyclooxygenase-2 (COX-2) expression. This effect was attenuated by a PPAR-␥ inhibitor [2-chloro-5-nitro-N-phenylbenzamide (GW9662)], by transfection with a dominant-negative PPAR construct, and was reproduced by the PPAR-␥ ligand rosiglitazone. At higher concentrations (1-10 M), 15d-PGJ 2 inhibited IL-1-stimulated PGE 2 and cytokine production and COX-2 expression, and this effect was not blocked by GW9662. Rosiglitazone at high concentrations (1-10 M) stimulated PGE 2 production in the absence or presence of the dominant-negative PPAR. The PPAR-␦ ligand GW501516 also inhibited IL-1-stimulated PGE 2 production but only at high concentrations (1 M). IL-1-induced nuclear factor-B (NF-B) DNA binding activity was significantly inhibited by 15d-PGJ 2 (10 M) and GW501516 (1 M) but increased with 10 M rosiglitazone. We conclude that 1) at low concentrations, 15d-PGJ 2 acts through a PPAR-␥ signaling pathway; b) at higher concentrations, its actions are mediated most likely through other pathways such as activation of PPAR-␦ and/or inhibition of NF-B; and 3) rosiglitazone exerts PPAR-independent effects at high concentrations (Ͼ1 M).Proinflammatory cytokines have been shown to play crucial roles in the maintenance of human pregnancy and the initiation of parturition (Romero et al., 1993;Mitchell et al., 1995). The presence of intrauterine infection has been shown to result in the local expression and secretion of proinflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor-␣, IL-6, and IL-8 (Romero et al., 1993;Dudley et al., 1996;Keelan et al., 1999a), which act locally on intrauterine cells to induce the release of inflammatory mediators, extracellular matrix-remodeling enzymes (So et al., 1992;Draper et al., 1995), and prostaglandins (PGs) through altered expression of prostanoid biosynthetic enzymes including fatty acid cyclooxygenase-2 (COX-2) Hansen et al., 1999;Kniss, 1999;Rauk and Chiao, 2000).Although most studies to date have focused on the produc- Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org. doi:10.1124/mol.104.009449.ABBREVIATIONS: IL, ...